Ribas and patient
UCLA
UCLA's Dr. Antoni Ribas (right) with Tom Stutz, whose health improved dramatically after treatment with the newly approved drug.
Ribas and patient
UCLA
UCLA's Dr. Antoni Ribas (right) with Tom Stutz, whose health improved dramatically after treatment with the newly approved drug.